Insights from 2025 ASCO® GI Annual Meeting


 

ASCO® GI 2025 Insights: Phase 1b Study of Gemcitabine & Nab-Paclitaxel in Combination With Lixumistat for Treatment-Naïve mPDAC

101 views
February 3, 2025
Comments 0
Login to view comments. Click here to Login